Congress-AAN
Congress-AAN

Transthyretin Amyloidosis (ATTR)

American Academy of Neurology (AAN) 2026

Congress Details

calanderApril 18-22, 2026

location Chicago, IL, USA

The material below is provided to support scientific exchange and pertains to select congress resources. Any content about investigational therapeutics or investigational uses of locally approved products does not establish the safety or efficacy of these therapeutics or uses, and there is no guarantee of local regulatory approval.

All congress materials are copyrighted by Alnylam. Permission is required to copy or distribute.

For questions beyond a product’s authorized indications or for information not available here, please contact Alnylam Medical Information.

Image
Oral

Agenda

20 April, 2026

Coming soon
Image
icon Presentation Type
Poster
Image
time icon Time
5:00 PM – 6:00 PM CST
Image
location icon Location
Monitor 007, Room 9
Image
icon Title
Design and rationale of TRITON-PN, a phase 3 study to evaluate the efficacy of nucresiran in patients with transthyretin amyloidosis with polyneuropathy
mic Presenter

Alejandra Gonzalez-Duarte

NYU Grossman School of Medicine, NY, USA